Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
219
-
Total 13F shares, excl. options
-
64.1M
-
Shares change
-
+2.17M
-
Total reported value, excl. options
-
$6.75B
-
Value change
-
+$155M
-
Put/Call ratio
-
1.79
-
Number of buys
-
123
-
Number of sells
-
-91
-
Price
-
$105.39
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q3 2021
262 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q3 2021.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 219 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.1M shares
of 1.09B outstanding shares and own 5.87% of the company stock.
Largest 10 shareholders include Capital World Investors (6.65M shares), BAILLIE GIFFORD & CO (4.9M shares), Invesco Ltd. (4.7M shares), BlackRock Inc. (3.99M shares), FMR LLC (3.78M shares), WELLINGTON MANAGEMENT GROUP LLP (3.61M shares), BRILLIANCE ASSET MANAGEMENT LTD (3.09M shares), VIKING GLOBAL INVESTORS LP (2.93M shares), VANGUARD GROUP INC (2.18M shares), and FEDERATED HERMES, INC. (1.87M shares).
This table shows the top 219 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.